Epocrates and athenahealth, which bought Epocrates for $293 million at the beginning of this year, launched their first joint product, a free mobile app called Epocrates Bugs + Drugs that uses big data to address "superbugs" or drug-resistant bacteria.
"What's exciting about this is it takes athena data and it pulls the big data into a moment of care that allows a physician to provide a...
